• MILATUZUMAB CHEMBL1743040 Antineoplastic

    Alternate Names:

    Milatuzumab
    IMMU-115
    hLL1
    252166479
    8267

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    Drug Class Therapeutic Antibodies
    (0 More Sources)

    Publications:

  • Interaction Types:
    antagonist
    antibody

    Interaction Info:
    Specific Action of the Ligand Binding
    Endogenous Drug? False
    Direct Interaction? True

    Publications:

    • Version: 20-Jun-2017

    Alternate Names:
    HLL1 Development Name
    MILATUZUMAB Generic Name

    Drug Info:
    Drug Class Therapeutic Antibodies

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    MILATUZUMAB GuideToPharmacology Ligand Name
    252166479 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: